No significant safety issues arose in VR-IWS use; one young participant reported minor dizziness in one session only¶
Claim · All claims
Evidence · 1 study · designr2·q2
Currency · newest study 2024 · not yet checked against its sources · not reviewed by a person
Subclaims¶
Reading the evidence codes
q is the design tier, i the impact, n the sample, and the kind with its r
the rigour judged within that kind: what each code means.
This claim: no standardized effect is recorded in observations/ for it yet, so no benchmark reading is possible.
q2 i? Across 21 participants, only one 6-year-old with intellectual disability felt dizzy and uncomfortable in session 1, which did not recur in session 2; no significant safety issues were identified. → Herrera 2024
Evidence¶
Herrera 2024¶
Herrera, G., Vera, L., Pérez-Fuster, P., López-Fernández, A., López, Á., Savaş-Taşkesen, Ü., & Newbutt, N. (2024). Multisite usability and safety trial of an immersive virtual reality implementation of a work organization system for autistic learners: implications for technology design. Education Tech Research Dev. https://doi.org/10.1007/s11423-024-10422-5
q2 · i? · design · r2
Safety evaluation in the multisite trial used exclusion criteria (seizures, migraines, vertigo), session limits of 3–5 activities, and post-session safety questionnaires after every session. The article reports only one of the 21 participants had minor adverse effects, confined to session 1.
"On the safety evaluation, only one of the 21 participants, Antonio, who was 6 years old with accompanying intellectual differences (also identified as ES-4), felt a bit dizzy and uncomfortable with his hands and eyes in session 1; however, this did not happen to him in Session 2."
Discussion¶
Learner Variables¶
- Safety — outcome: instruction changes it
Related Claims¶
- All 21 autistic students independently completed all 164 VR-IWS tasks offered across three countries — related
- Motion sickness after the iVR experience was negligible for most participants, but a minority felt significant discomfort — related
- VR sickness in the system is minimal overall (SSQ total 12.88), with nausea lowest and oculomotor symptoms most significant — related
Page metadata
| Field | Value |
|---|---|
type |
claim |
id |
vr-iws-no-significant-safety-issues |
title |
No significant safety issues arose in VR-IWS use; one young participant reported minor dizziness in one session only |
description |
No significant safety issues arose in VR-IWS use; one young participant reported minor dizziness in one session only |
status |
review |
evidence_strength |
moderate |
newest_evidence |
2024 |
generated |
by process:wiki-ingest on 2026-10-29 |
trust |
unverified — no one has confirmed this page's content |
sources |
1 — herrera-2024 |
Frontmatter is the page's machine-readable record — see the Schema & Guide.